These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

817 related articles for article (PubMed ID: 29658109)

  • 1. PGE
    Lin MC; Chen SY; He PL; Herschman H; Li HJ
    Int J Cancer; 2018 Sep; 143(6):1440-1455. PubMed ID: 29658109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PGE
    Lin MC; Chen SY; Tsai HM; He PL; Lin YC; Herschman H; Li HJ
    Stem Cells; 2017 Feb; 35(2):425-444. PubMed ID: 27506158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 Induces Breast Cancer Stem Cells via EP4/PI3K/AKT/NOTCH/WNT Axis.
    Majumder M; Xin X; Liu L; Tutunea-Fatan E; Rodriguez-Torres M; Vincent K; Postovit LM; Hess D; Lala PK
    Stem Cells; 2016 Sep; 34(9):2290-305. PubMed ID: 27301070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells.
    Park SY; Kim MJ; Park SA; Kim JS; Min KN; Kim DK; Lim W; Nam JS; Sheen YY
    Oncotarget; 2015 Nov; 6(35):37526-43. PubMed ID: 26462028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.
    Kurtova AV; Xiao J; Mo Q; Pazhanisamy S; Krasnow R; Lerner SP; Chen F; Roh TT; Lay E; Ho PL; Chan KS
    Nature; 2015 Jan; 517(7533):209-13. PubMed ID: 25470039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties.
    Kundu N; Ma X; Kochel T; Goloubeva O; Staats P; Thompson K; Martin S; Reader J; Take Y; Collin P; Fulton A
    Breast Cancer Res Treat; 2014 Jan; 143(1):19-31. PubMed ID: 24281828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of GSK3 and MEK induced cancer stem cell generation via the Wnt and MEK signaling pathways.
    Liao S; Gan L; Qin W; Liu C; Mei Z
    Oncol Rep; 2018 Oct; 40(4):2005-2013. PubMed ID: 30066938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of the S1P
    Filipenko I; Schwalm S; Reali L; Pfeilschifter J; Fabbro D; Huwiler A; Zangemeister-Wittke U
    Biochim Biophys Acta; 2016 Nov; 1861(11):1840-1851. PubMed ID: 27616330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 receptor EP4 as the common target on cancer cells and macrophages to abolish angiogenesis, lymphangiogenesis, metastasis, and stem-like cell functions.
    Majumder M; Xin X; Liu L; Girish GV; Lala PK
    Cancer Sci; 2014 Sep; 105(9):1142-51. PubMed ID: 24981602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-Induced Extracellular Vesicle miRNAs Promote Breast Cancer Stemness by Targeting
    Shen M; Dong C; Ruan X; Yan W; Cao M; Pizzo D; Wu X; Yang L; Liu L; Ren X; Wang SE
    Cancer Res; 2019 Jul; 79(14):3608-3621. PubMed ID: 31118200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective mode of action of plumbagin through BRCA1 deficient breast cancer stem cells.
    Somasundaram V; Hemalatha SK; Pal K; Sinha S; Nair AS; Mukhopadhyay D; Srinivas P
    BMC Cancer; 2016 May; 16():336. PubMed ID: 27229859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COX-2 induces oncogenic micro RNA miR655 in human breast cancer.
    Majumder M; Dunn L; Liu L; Hasan A; Vincent K; Brackstone M; Hess D; Lala PK
    Sci Rep; 2018 Jan; 8(1):327. PubMed ID: 29321644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of PGE2-induced EP4 expression on snail signaling and the impact on epithelial-mesenchymal transition: significance of EP4 antagonism.
    Kim HN; Narayanan NK; Lasano S; Narayanan B
    Anticancer Res; 2011 Dec; 31(12):4347-57. PubMed ID: 22199300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo.
    Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B
    Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer.
    Kochel TJ; Reader JC; Ma X; Kundu N; Fulton AM
    Oncotarget; 2017 Jan; 8(4):6540-6554. PubMed ID: 28029661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells.
    Xia W; Lo CM; Poon RYC; Cheung TT; Chan ACY; Chen L; Yang S; Tsao GSW; Wang XQ
    Oncotarget; 2017 Jun; 8(24):38811-38824. PubMed ID: 28415588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo antiproliferative activity of metformin on stem-like cells isolated from spontaneous canine mammary carcinomas: translational implications for human tumors.
    Barbieri F; Thellung S; Ratto A; Carra E; Marini V; Fucile C; Bajetto A; Pattarozzi A; Würth R; Gatti M; Campanella C; Vito G; Mattioli F; Pagano A; Daga A; Ferrari A; Florio T
    BMC Cancer; 2015 Apr; 15():228. PubMed ID: 25884842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
    Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
    Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential.
    Knezevic J; Pfefferle AD; Petrovic I; Greene SB; Perou CM; Rosen JM
    Oncogene; 2015 Dec; 34(49):5997-6006. PubMed ID: 25746005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.